Drägerwerk stock gains 2.65% before market to EUR 104.50
Published on 11/10/2026 at 08:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness outlook remains in focus
- Dräger develops medical and safety technology for hospitals, emergency services and industry.
- Current 2026 guidance calls for currency-adjusted sales growth of 2.0 to 6.0 percent and an EBIT margin of 6.0 to 8.0 percent.
Drägerwerk stock traded at EUR 104.50 on Lang & Schwarz at 08:29 CET on Tuesday, November 10, 2026, 2.65 percent above the Xetra close of Monday, November 9, 2026 at EUR 101.80.
Business outlook remains in focus
Dräger develops products and system solutions for medical and safety applications. Its technology is used in hospitals, by fire departments and emergency services, in mining, government agencies and industry.
On its Investor Relations page, the company presents its current 2026 outlook. Dräger expects currency-adjusted revenue growth of 2.0 to 6.0 percent and an EBIT margin between 6.0 and 8.0 percent. The company also targets a gross margin between 44.0 and 46.0 percent.
The guidance places margin execution alongside sales growth at the center of the investment case. For the stock, the next market focus is whether demand across medical and safety technology can support the stated profitability range.
Drägerwerk stock trades within the German equity market, alongside companies represented by the DAX.
